These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7188516)

  • 1. [Purity requirements for drugs].
    Battaglino G
    Ann Ist Super Sanita; 1982; 18(4):615-20. PubMed ID: 7188516
    [No Abstract]   [Full Text] [Related]  

  • 2. [Examples of purity criteria for steroid drugs].
    Cavina G; Moretti G; Alimenti R; Gallinella B; Porrà R; Valvo L
    Ann Ist Super Sanita; 1982; 18(4):677-80. PubMed ID: 7188524
    [No Abstract]   [Full Text] [Related]  

  • 3. Quality control of absolute bacteria removal filters.
    Pall DB
    Bull Parenter Drug Assoc; 1975; 29(4):192-204. PubMed ID: 1131463
    [No Abstract]   [Full Text] [Related]  

  • 4. [Problems of control of polymers used in drug technology].
    Krówczyński L
    Polim Med; 1984; 14(1-4):5-12. PubMed ID: 6533635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The microbiology of medication: concept - elaboration - control].
    Lagodsky H; Blanchard JC; Jandard M; Migne J
    Biol Med (1971); 1973 Dec; 2(2):141-56. PubMed ID: 4807318
    [No Abstract]   [Full Text] [Related]  

  • 6. PDA presentation at FDA Open Conference on Sterile Drug Manufacturing. Parenteral Drug Association.
    J Pharm Sci Technol; 1994; 48(1):4-6. PubMed ID: 8004417
    [No Abstract]   [Full Text] [Related]  

  • 7. [Criteria of purity and specifications, an essential premise to the beginning of any toxicological investigation].
    Gatti GL
    Ann Ist Super Sanita; 1982; 18(4):641-2. PubMed ID: 7188520
    [No Abstract]   [Full Text] [Related]  

  • 8. [Study concept of traditional Chinese medicine quality standards].
    Chen J; Chen L; An Z; Chang Z; Yuan X; Zhan Y
    Zhong Yao Cai; 2002 Oct; 25(10):748-50. PubMed ID: 15562726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cause and measure of short of quality control on Chinese medicine herbs].
    Chen J; Chen L; An Z; Yu X; Zhan Y
    Zhong Yao Cai; 2003 Jan; 26(1):43-6. PubMed ID: 12858774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A new secondary chemical: the purity of products].
    Cernia E
    Ann Ist Super Sanita; 1982; 18(4):637-40. PubMed ID: 7188519
    [No Abstract]   [Full Text] [Related]  

  • 11. [Microbial purity of drugs. I. Development of requirements for microbial purity and results of evaluation of the microbial quality of drugs].
    Bábik I; Chalabala M; Sagáth J
    Cesk Farm; 1977 Oct; 26(8):383-8. PubMed ID: 608200
    [No Abstract]   [Full Text] [Related]  

  • 12. [Health precautions and purity requirements of refined chemicals].
    Macrì A; Salvatore G; Silano V
    Ann Ist Super Sanita; 1982; 18(4):621-31. PubMed ID: 7188517
    [No Abstract]   [Full Text] [Related]  

  • 13. Validation study on how to avoid microbial contamination during pharmaceutical production.
    Shintani H
    Biocontrol Sci; 2015; 20(1):1-10. PubMed ID: 25817807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Standards of good production. Problems of sampling].
    Fontani F; Sekules G; Zanotti Gerosa A
    Boll Chim Farm; 1975 Feb; 114(2):57-69. PubMed ID: 1203102
    [No Abstract]   [Full Text] [Related]  

  • 15. [Maintaining standards of good compounding (N.B.F.)].
    Castoldi B; Fumagalli A; Mazzoldi G
    Boll Chim Farm; 1978 Dec; 117(12):689-99. PubMed ID: 752351
    [No Abstract]   [Full Text] [Related]  

  • 16. [Standards of good production. Human and technical aspects].
    Rocchi B
    Boll Chim Farm; 1975 Jan; 114(1):3-9. PubMed ID: 1203097
    [No Abstract]   [Full Text] [Related]  

  • 17. New particle counter for nondestructive monitoring of parenterals.
    Porter MC
    Bull Parenter Drug Assoc; 1975; 29(4):169-82. PubMed ID: 1131461
    [No Abstract]   [Full Text] [Related]  

  • 18. Risk management, cGMP, and the evolution of aseptic processing technology.
    Agalloco J; Akers J; Baseman H; Boeh R; Madsen R; Ostrove S; Pavell A
    PDA J Pharm Sci Technol; 2009; 63(1):8-10. PubMed ID: 19455938
    [No Abstract]   [Full Text] [Related]  

  • 19. [Microbiological aspects of the pharmaceutical environment].
    Buogo A; Guerrato G; Giulioni A; Papakristo G
    Boll Chim Farm; 1979 Jan; 118(1):9-17. PubMed ID: 454532
    [No Abstract]   [Full Text] [Related]  

  • 20. Future development of harmonized guidelines.
    Hayakawa T
    Dev Biol Stand; 1996; 88():331-2. PubMed ID: 9119158
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.